Liver Damage Preferentially Results from CD8+ T Cells Triggered by High Affinity Peptide Antigens

JQ Russell, GJ Morrissette, M Weidner… - The Journal of …, 1998 - rupress.org
JQ Russell, GJ Morrissette, M Weidner, C Vyas, D Aleman-Hoey, RC Budd
The Journal of experimental medicine, 1998rupress.org
Little is understood of the anatomical fate of activated T lymphocytes and the consequences
they have on the tissues into which they migrate. Previous work has suggested that
damaged lymphocytes migrate to the liver. This study compares class I versus class II major
histocompatibility complex (MHC)–restricted ovalbumin-specific T cell antigen receptor
(TCR) transgenic mice to demonstrate that after in vivo activation with antigen the
emergence of CD4− CD8− B220+ T cells occurs more frequently from a CD8+ precursor …
Little is understood of the anatomical fate of activated T lymphocytes and the consequences they have on the tissues into which they migrate. Previous work has suggested that damaged lymphocytes migrate to the liver. This study compares class I versus class II major histocompatibility complex (MHC)–restricted ovalbumin-specific T cell antigen receptor (TCR) transgenic mice to demonstrate that after in vivo activation with antigen the emergence of CD4CD8B220+ T cells occurs more frequently from a CD8+ precursor than from CD4+ T cells. Furthermore, this change in phenotype is conferred only by the high affinity native peptide antigen and not by lower affinity peptide variants. After activation of CD8+ cells with only the high affinity peptide, there is also a dramatically increased number of liver lymphocytes with accompanying extensive hepatocyte damage and elevation of serum aspartate transaminase. This was not observed in mice bearing a class II MHC–restricted TCR. The findings show that CD4CD8B220+ T cells preferentially derive from a CD8+ precursor after a high intensity TCR signal. After activation, T cells can migrate to the liver and induce hepatocyte damage, and thereby serve as a model of autoimmune hepatitis.
rupress.org